Clinical Trial Update: Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update describes a phase 1/2 study evaluating Carmustine followed by surgery in patients with recurrent supratentorial malignant glioma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Malignant Glioma

Drugs mentioned

• Carmustine (carmustine)

Snippet

Sponsor: Direct Therapeutics | Conditions: Brain and Central Nervous System Tumors, Metastatic Cancer | Phase 1, Phase 2 | Status: UNKNOWN